J

Javid J. Moslehi

Cardiovascular Institute of the South

ORCID: 0000-0001-5443-4312

Publishes on Cancer Immunotherapy and Biomarkers, Chemotherapy-induced cardiotoxicity and mitigation, Chronic Lymphocytic Leukemia Research. 487 papers and 43.7k citations.

PubIndex Score98Top 2%How it's scored

487Publications

43.7kTotal Citations

First publication: 1997First senior author: 2011

Cancer Immunotherapy and Biomarkers Chemotherapy-induced cardiotoxicity and mitigation Chronic Lymphocytic Leukemia Research CAR-T cell therapy research Viral Infections and Immunology Research

Top publicationsby citations

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Alexander R. Lyon, Julia Grapsa, Teresa López‐Fernández et al.|European Heart Journal|2022

Cited by 2.7k

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

Douglas B. Johnson, Javid J. Moslehi, Justin M. Balko et al.|New England Journal of Medicine|2016

Cited by 2.3k

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

Syed Mahmood, Tomas G. Neilan, Dipti Gupta et al.|Journal of the American College of Cardiology|2018

Cited by 1.5k

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

Saro H. Armenian, Daniel J. Lenihan, Christina Lacchetti et al.|Journal of Clinical Oncology|2017

Cited by 1.3k

Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society

Alexander R. Lyon, Daniel J. Lenihan, Teresa López‐Fernández et al.|European Journal of Heart Failure|2020

Cited by 767